Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, the company provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, it offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.…
Milestone Scientific (MLSS) Q3 2026 Earnings Call Transcript
Milestone Scientific (NYSEAMERICAN: MLSS) is listed on NYSE American, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 15 employees.
The shares were at 0.2400 USD on 20 November 2026, down 38.5% over 52 weeks. Its 52-week range is 0.2200 USD to 0.5796 USD: the price is 58.6% below the high and 9.1% above the low.
Its market capitalisation is 21.75M USD.
Milestone Scientific reports return on equity of -203.4%, an operating margin of -38.1% and revenue down 5.9% year over year.
It holds more cash than debt, a net cash position of 1.20M USD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. The next earnings report is expected on 30 March 2027.